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In contrast to mammals, in the chicken major sites of lipoprotein synthesis and secretion are not only the
liver and intestine, but also the kidney and the embryonic yolk sac. Two key components in the assembly
of triglyceride-rich lipoproteins are the microsomal triglyceride transfer protein (MTP) and apolipo-
protein B (apoB). We have analyzed the expression of MTP in the embryonic liver, small intestine, and
kidney, and have studied the expression of MTP in, and the secretion of apoB from, the developing yolk
sac (YS). Transcript and protein levels of MTP increase during embryogenesis in YS, liver, kidney, and
small intestine, and decrease in YS, embryonic liver, and kidney after hatching. In small intestine, the
MTP mRNA level rises sharply during the last trimester of embryo development (after day 15), while MTP
protein is detectable only after hatching (day 21). In the YS of 15- and 20-day old embryos, apoB
secretion was detected by pulse-chase metabolic radiolabeling experiments and subsequent immuno-
precipitation. Taken together, our data reveal the importance of coordinated production of MTP and apoB
in chicken tissues capable of secreting triglyceride-rich lipoproteins even before hatching.
 2014 The Authors. Published by Elsevier Masson SAS. Open access under CC BY license.1. Introduction
The major structural protein of triglyceride-rich lipoproteins
secreted by the liver and intestine is apolipoprotein B (apoB). The
microsomal triglyceride transfer protein (MTP) plays amajor role in
the synthesis and secretion of apoB-containing lipoproteins [1].
MTP is located in the lumen of the endoplasmic reticulum (ER) and
is involved in the initial loading of nascent lipoproteins with
neutral lipids, particularly triglycerides and cholesterol esters.
Alternatively, or additionally, MTP may participate in the intricate
process of apoB translocation across the ER membrane [2]. In
humans, MTP has been shown to be involved in the biogenesis of
lipoproteins containing apolipoprotein B100 in the liver and
apolipoprotein B48 in the small intestine [3e5]; for review see Ref.
[6].
Studies of human embryos showed expression of apoB RNA in
the fetal liver, fetal intestine, and in the yolk sac (YS), but not in
other embryonic tissues [7e9]. MTP and apoB are also expressed in
the human placenta, suggesting that this organ can also synthesizex: þ43 1 4277 9618.
.at (M. Hermann).
r Masson SAS. Open access under CC BY and secrete apoB-containing lipoproteins [10]. During mouse em-
bryonic development, MTP is expressed in the YS as well as in liver
and small intestine [11,12], but not in cardiac and renal tissues. In
the laying hen, it has been shown that MTP is expressed in tissues
involved in lipid metabolism, i.e., the liver, small intestine, and the
kidney [13]. Chicken liver synthesizes and secretes apoB100-
containing lipoproteins, but apoB48 production is totally absent
in any organ of chickens. Interestingly, chicken small intestine se-
cretes so-called portomicrons, which are apoB100-containing li-
poproteins [14,15].
Genetic deﬁciency of MTP in humans results in the autosomal
recessive disease, abetalipoproteinemia [16,17]. The pathophysi-
ology of this inherited condition may be attributed, at least in
part, to the impaired absorption of the fat-soluble vitamins A and
E [18,19]. Gene defects leading to structurally altered apoB secreted
from the liver or intestinal mucosa results in hypobetali
poproteinemia [20e24], which also is associated with fat-soluble
vitamin deﬁciencies in humans. In liver and intestine of heterozy-
gous MTP knockout mice, the MTP mRNA and protein levels were
reduced by 50%, and a marked reduction in total plasma cholesterol
levels was observed. Studies of MTP knockout mouse embryos
showed an impaired capacity of the YS to export lipids to the
developing embryo and demonstrated an accumulation of cytosolic
lipid droplets in the endodermal cells of the yolk sac, followed by
lethal developmental abnormalities [25].license.
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supplies the growing embryo with nutrients taken up from the
yolk. Acquisition of this function is a process which is coordinated
with that of vascularization of the YS [26]. MTP has been identiﬁed
in chicken YS [26,27], but the expression of MTP in fetal tissues has
not been studied in detail yet. We now show that MTP is expressed
not only in the YS of the developing chicken embryo, but also in
fetal liver, intestine, and kidney. Secretion of newly synthesized
apoB in ex-vivo cultured YS tissue, which also synthesizes MTP, is
compatible with the notion that this tissue exports triglyceride-rich
lipoproteins to the embryonic circulation.
2. Material and methods
2.1. Animals
Sexually mature Derco brown (TETRA-SL) laying hens and
roosters were purchased fromDiglas Co. (Feuersbrunn, Austria) and
maintained on open ﬂoor space with free access to water and feed
(standard diet, Ssniff, Germany) under a daily light period of 16 h.
For fertilized eggs, hens and roosters were housed together in
ﬂocks in our animal facility. Freshly fertilized eggs available in
house were incubated at 37.5 C and 60e70% humidity to maintain
normal embryonic development. Pre-hatch eggs were removed
from the incubator after 5, 7, 9, 10, 11, 13, 15, 17, 20 days; 1-day-old
and 3-day-old chicks were also utilized. For tissue and organ
retrieval, the chicks were euthanized by decapitation. The shell of
eggs incubated for up to 20 dayswas cut open to expose the embryo
for tissue preparation (liver, kidney, and small intestine); the YS
membranes were excised, washed with ice-cold phosphate-buff-
ered saline (PBS), and protease inhibitors (Complete, Roche, Man-
heim, Germany) were added to PBS buffer prior to the preparation
of Triton X-100 protein extracts. For tissue and organ retrieval, the
laying hens were euthanized by decapitation. All animal pro-
cedures were approved by the “Animal Care and Use Committee” of
the Medical University of Vienna.
2.2. Preparation of antibodies
Polyclonal antibodies directed against a chickenMTP C-terminal
fragment [13], and against chicken apoB100 [28] were raised by a
standard procedure in adult female New Zeeland White rabbits in
our laboratory. Antisera were tested by Western blotting.
2.3. Preparation of yolk sac layers and tissue culture
Chicken eggs were incubated to embryonic day (E) 9. YS tissue
from E9 embryos was washed in PBS. Separation of layers was
performed in PBS using watchmakers’ forceps. Starting from the
mesodermal layer containing blood vessels, the endodermal
epithelial cell (EEC) layer and themesodermwere peeled apart. The
separated layers were immediately used for protein isolation.
For ex-vivo culture, yolk sacs were isolated from 15 or 20 days
old embryos, and small pieces of 0.5e0.7 cm2 were cut off and
incubated in DMEM D-Valine medium supplemented with 10% fetal
calf serum, 2% horse serum, 100 units penicillin/ml, 0.1 mg/ml
streptomycin, 1% fungizone and 2 mM L-glutamine, which was
changed every day. The tissue fragments were incubated two days
to remove the adherent yolk before use in experiments.
2.4. Metabolic labeling and immunoprecipitation
Cultured YS tissue specimenswerewashed in PBS and incubated
in starvation medium (RPMI 1640 without L-glutamine, L-methio-
nine, L-cysteine and L-cystine) for 1 h at 37 C and 5% CO2.Thereafter, the medium was removed and the YS fragments were
metabolically labeled in starvation medium with Met-label ([35S]
methionine and [35S]cysteine) for 1 h. After the pulse phase, the
labeling medium was removed and the YS tissue-pieces were
incubated in medium as described above, supplemented with
200 mM L-glutamine, 400 mM L-methionine, 400 mM L-cysteine
and L-cystine. After the indicated chase times, the supernatant was
processed as follows. For immunoprecipitation, 500 ml of the su-
pernatant were incubated with the anti-ApoB100 IgG (1:100) and
protein A-Sepharose beads (40 ml wet volume) for 16 h at 4 C. The
protein A-Sepharose beads were washed 5 times with PBS, sus-
pended in Laemmli sample buffer containing 150 mM 2-mercapto-
ethanol and heated to 95 C for 5 min. After electrophoresis on a
denaturing 10% polyacrylamide gel, the gel was ﬁxed (10% acetic
acid, 30% methanol), treated for ﬂuorography with EN3HANCE so-
lution, dried, and X-ray ﬁlms were exposed at 80 C for 24 h to 8
days and quantiﬁcations were performed with ImageJ analysis
program.
2.5. Preparation of membrane protein extracts and determination
of protein concentrations
Triton X-100 extracts from various tissues prepared from
chicken embryos of different developmental stages, from hatched
chicks, or from laying hens were prepared as described previously
[29]. These samples were used immediately or were quick-frozen in
liquid nitrogen and stored at 80 C until use. Protein concentra-
tions were determined by the method of Bradford (BioRad, Her-
cules, California, USA) with bovine serum albumin as standard.
2.6. SDS-polyacrylamide gel electrophoresis and immunoblotting
For Western blotting, aliquots of extracts were subjected to 10%
SDS-PAGE under reducing or non-reducing conditions, and the
separated proteins were electrophoretically transferred to nitro-
cellulose membranes (Hybond-C Extra, Amersham Biosciences,
Little Chalfont, UK). The amounts loaded were monitored by
Ponceau-S staining of the membranes. Nonspeciﬁc binding sites
were blocked with TBS (20mM TriseHCl, pH 7.4, and 137mMNaCl)
containing 5% (w/v) nonfat dry milk and 0.1% Tween-20 (blocking
buffer) for 1 h at room temperature. GgMTP was detected with
rabbit anti-ggMTP antiserum (1:5000) followed by incubationwith
HRP-conjugated goat anti-rabbit IgG (1:50,000, Sigma) and devel-
opment with the enhanced chemiluminescence protocol (Pierce,
Rockford, Illinois, USA). Quantiﬁcations were performed with
AlphaEaseFC analysis program. The sizes of proteins were esti-
mated with a Precision Plus Protein molecular mass standard (10e
250 kDa) from Bio-Rad (Hercules, California, USA).
2.7. Preparation of total RNA, cDNA synthesis, PCR, DNA cloning,
and sequencing
Total RNA from the indicated galline tissues was extracted using
the NucleoSpin RNA II kit (Macherey-Nagel, Dueren, Germany)
following the manufacturer’s instructions. These samples were
used immediately or stored at 80 C until use. Single-stranded
cDNA was synthesized using SuperScript II reverse transcriptase
(Invitrogen, Carlsbad, California, USA) and oligo(dT)18-primer. PCR
ampliﬁcation was performed with a T3000 Thermocycler (Bio-
metra, Goettingen, Germany) with a touch-down program using
the High Fidelity PCR Enzyme Mix (Fermentas, St. Leon-Rot, Ger-
many). The ampliﬁed products were subjected to 1% agarose gel
electrophoresis and stained with ethidium bromide. Subsequently,
the PCR product was excised from the gel, and DNA was puriﬁed
with Xact Extraction Kit (GenXpress, Wiener Neudorf, Austria). The
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TOPO TA Cloning kit (Invitrogen, Carlsbad, California, USA), and
subsequently transformed into E. coli Top10 cells. The plasmids
were isolated using FastPlasmid Mini Kit (5Prime, Hilden, Ger-
many). Plasmids were sent to Agowa GmbH, Berlin, Germany for
sequence analysis. The following G. gallus (gg)MTP-speciﬁc primers
were used: forward primer 50-GCT AGC CTT TTC CAG CTA C-30 and
reverse primer 50-ATT TTG GCA CCT GTT TTT CG-30.
2.8. Quantitative real time PCR
Quantitative Real Time PCR (qPCR) was performed with the
LightCycler 480 system (Roche, Manheim, Germany) using the
LightCycler FastStart DNA Master SYBR Green I kit (Roche, Man-
heim, Germany). The following primers were used: ggMTP, forward
primer 50-GCT AGC CTT TTC CAG CTA C-30 and reverse primer 50-
ATT TTG GCA CCT GTT TTT CG-30; and ggb-actin, forward primer 50-
AGC TAT GAA CTC CCT GAT GG-30 and reverse primer 50-ATC TCC
TTC TGC ATC CTG TC-30.
Diluted cDNA samples were used for all qPCR reactions. Serial
dilutions of 101e109 of the target PCR products were freshly
prepared. All samples were analyzed in triplicate measurement
S.E. from three different incubated eggs or animals. The relative
quantiﬁcation in gene expression was determined using 2DDCt
method [30]. Using this method, the -fold changes in gene
expression normalized to an internal control gene are obtained.
Here, chicken b-Actin mRNA levels were measured as house-
keeping gene and used for normalization. Values are expressed in
arbitrary units (AU).
2.9. Immunocytochemistry
Freshly isolated tissues were used for parafﬁn- or cryo-sections.
For parafﬁn sections, tissues were ﬁxed overnight in 4% para-
formaldehyde and embedded in parafﬁn using an Excelsior
embedding machine. Sections of 8 mm were cut on a LeicaRM2155
microtome, ﬁxed on Polysine slides (Menzel-Glaeser, Braunsch-
weig, Germany), and dried o/n at 37 C or for 1 h at 50 C. The slices
were deparafﬁnized in xylol exchange medium XEM-200 (Vogel,
Giessen, Germany) by gentle shaking for 20 min. For rehydration,
the tissues were washed consecutively in 100%, 90%, 70%, 50%, and
30% ethanol.
Nonspeciﬁc binding of antibodies was inhibited by blocking
with PBS containing 1% BSA and 3% inactivated goat serum for 1 h at
RT. The sections were incubated overnight at 4 C with the
appropriate antibodies in blocking solution (rabbit anti ggMTP
1:100, rabbit pre-immune serum 1:100). The sections were rinsed
3  5 min in PBS and incubated with biotinylated goat a-rabbit
secondary antibody (1:500, Sigma) for 1 h at room temperature.
After rinsing 3  5 min in PBS, the slides were incubated with
Streptavidin Peroxidase Polymer (1:200, Sigma, SigmaeAldrich,
Vienna, Austria) for 20 min. For the color reaction, the sections
were incubated with AEC (3-amino-9-ethylcarbazol) substrate-
chromogen (ready-to-use solution, DAKO, Vienna, Austria). The
specimens were mounted in Glycergel Mounting Medium (DAKO,
Vienna, Austria) and analyzed by light microscopy (Axiovert 10,
Zeiss, Jena, Germany).
Cryosections were prepared from frozen tissue, embedded in
O.C.T. Compound Tissue-Tek from Sakura at 24 C. Sections of
7 mmwere cut on a HM500OMmicrotome, ﬁxed on SuperFrost Plus
slides (Menzel-Glaeser, Braunschweig, Germany) and stored
at 20 C. For speciﬁc detection of proteins, the sections were
incubated at room temperature for 10 min, followed by incubation
in ice-cold acetoneemethanol 1:1 for 5 min with gentle shaking.
After rinsing 3  5 min in PBS, the slides were incubated with theappropriate primary antibody as described above, at 4 C in a hu-
mid chamber overnight. After rinsing 3  5 min in PBS, the slides
were incubated with the secondary biotinylated goat-anti-rabbit
antibody as described above.3. Results
To gain insight into MTP expression by the avian embryo, we
prepared liver, kidney and small intestine samples from different
stages of embryonic development (10, 15 and 20 days), and from 1
and 3 day old chicks, respectively. Unfortunately, due to technical
reasons, it was not possible to obtain these organs before day 10 of
development. In all experiments, tissues from mature laying hens
were used as controls.
First, we analyzed MTP expression in the liver of embryos and
hatched chicks (Fig. 1). As determined by qPCR, MTP transcript
levels in embryonic liver were detectable at the earliest time point
analyzed and rose steadily in the last trimester of embryogenesis
(after day 15, see Fig. 1A). One day after hatching, hepatic MTP
mRNA was still high, and then appeared to decrease slowly after
hatching, as observed in 3-day old chicks to the level observed in
mature laying hens. We also performed Western blot analysis of
liver membrane protein extracts from animals at the same devel-
opmental stages using our rabbit antiserum against chicken MTP
(Fig. 1B). The levels of MTP protein in general were in good agree-
ment with the transcript levels, with similar levels before (20 d)
and after hatching (1 d), and thereafter approached that in the liver
of laying hens. Western blotting results were quantiﬁed as
described in “Materials and Methods” to determine the MTP pro-
tein levels compared to that in laying hen liver. Next, immunohis-
tochemistry of embryonic liver from a 17-day old embryo with the
anti-ggMTP antiserum was performed (Fig. 1C), which revealed a
high level of MTP in the embryonic liver, in accordance with the
results obtained by qPCR and Western blot analysis. No staining
was observed when sections were incubated with pre-immune
serum (Fig. 1D).
To analyze MTP transcript levels in the kidney of embryos and
hatched chicks, quantitative PCR was performed (Fig. 2A). The
levels of mRNA remained constant from day 10e20 of embryo-
genesis, and increased after hatching. Next, the membrane protein
extracts from embryonic kidneys from 15- and 20-day old embryos
and from 1- and 3-day old chicken were subjected to Western blot
analysis using our anti-ggMTP antiserum (Fig. 2B). In accordance to
the quantitative PCR results, the MTP protein levels increased after
hatching. In the particular laying hen analyzed for protein levels,
expression of MTP was higher in liver than in kidney. The immu-
nohistochemical staining of the kidney of a 17-day old embryo and
of a laying hen with anti-ggMTP antiserum (Fig. 2C and E)
demonstrate the expression of MTP in the embryonic kidney. When
sections were incubated with pre-immune serum (Fig. 2D and F),
no staining was observed.
The quantitative analysis of MTP mRNA in small intestine of
embryos and hatched chicks showed very low transcript levels on
embryonic days 10 and 15, followed by a dramatic increase towards
day 20; the level remained stable for at least 3 days after hatching
(Fig. 3A). In mature hens, expression levels rose an additional 3-
fold. Western blot analysis showed that MTP protein levels in em-
bryonic small intestine likely rise only shortly before hatching and
are then clearly detectable after hatching (days 1 and 3). In accor-
dance with the results obtained by qPCR, MTP protein was sub-
stantially elevated in laying hens (Fig. 3B). The immunohisto
chemical staining of embryonic intestine from a 17 days old embryo
(Fig. 3C) and a laying hen (Fig. 3E) with anti-ggMTP antiserum
revealed the presence of MTP in the enterocytes lining the villi. No
Fig. 1. Expression of MTP in the developing chicken liver. A, transcript levels of chicken MTP in the liver were determined using qPCR as described in “Materials and methods
section”. Transcript levels are expressed as arbitrary units relative to those of chicken b-actin. B, analysis of chicken MTP protein levels by Western blotting. 10 mg of protein
per lane from the liver of the indicated developmental stages were separated by 10% SDS-PAGE under non-reducing conditions, blotted to nitrocellulose membranes and probed
with antiserum directed against MTP, followed by an HRP-coupled anti-rabbit secondary antibody as described in “Materials and methods section”. C and D, cryosections of the liver
from 17-day-old chicken embryos were prepared as described in “Materials and methods section”. The sections were stained with our rabbit anti-ggMTP antiserum (C) or with
corresponding pre-immune serum (D). Images were acquired using a light microscope. Magniﬁcation, 40-fold.
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immune serum (Fig. 3D and F).
We also determined the transcript levels of chicken MTP in the
YS during days 5e20 of embryo development, and from 1- and 3-
day old chicks, respectively. As positive control laying hen liver
was used. As shown in Fig. 4A, MTP RNA expression starts at the
end of the ﬁrst trimester of embryonic development, i.e., on orFig. 2. Expression of MTP in the chicken kidney during development. Transcript levels of MT
section”. Transcript levels are expressed as arbitrary units relative to those of chicken b-actin
from the kidneys of the indicated developmental stages were separated by 10% SDS-PAGE
antiserum directed against MTP, followed by an HRP-coupled anti-rabbit secondary antibod
day-old chicken embryos (C and D) and from laying hen (E and F) were prepared as describ
ggMTP antiserum (C and E) or with corresponding pre-immune serum (D and F). Images wabout day 7 of incubation, increases gradually during the growth of
the embryo, and is observed in the YS for at least 3 days after
hatching. The highest expression was found in the YS of 20-day old
embryos, i.e., at the end of embryonic development. Anti-ggMTP
antiserum was used to analyze the MTP protein levels by Western
blotting of YS extracts from the stages also analyzed at the tran-
script levels (Fig. 4B). As observed for mRNA, the levels of YS MTPP (A) in the kidney were determined using qPCR as described in “Materials and methods
. B, analysis of chicken MTP protein levels by Western blotting. 25 mg of protein per lane
under non-reducing conditions, blotted to nitrocellulose membranes and probed with
y as described in “Materials and methods section”. Cryosections of the kidney from 17-
ed in “Materials and methods section”. The sections were stained with our rabbit anti-
ere acquired using a light microscope. Magniﬁcation, 40-fold.
Fig. 3. Expression of MTP in the small intestine of the developing chicken. A, transcript levels of MTP in the small intestine were determined using qPCR as described in “Materials
and methods section”. Transcript levels are expressed as arbitrary units relative to those of chicken b-actin. B, analysis of MTP protein in the small intestine by Western blotting.
10 mg per lane of protein from livers of the indicated developmental stages were separated by 10% SDS-PAGE under non-reducing conditions, blotted to nitrocellulose membranes
and probed with antiserum directed against MTP, followed by an HRP-coupled anti-rabbit secondary antibody as described in “Materials and methods section”. Cryosections of the
small intestine parallel to the villi from 17-day-old chicken embryos (C and D) and from laying hen (E and F) were prepared as described in “Materials and methods section. The
sections were stained with our rabbit anti-ggMTP antiserum (C and E) or with corresponding pre-immune serum (D and F). Images were acquired using a light microscope.
Magniﬁcation, 40-fold.
Fig. 4. Expression of MTP in the developing chicken yolk sac. A, transcript levels of MTP in the chicken YS at the indicated day of development (d) and 1 and 3 days after hatching
were determined using qPCR as described in “Materials and methods section”. Transcript levels are expressed as arbitrary units relative to those of chicken b-actin. B and C, analysis
of MTP protein levels by Western blotting. 10 mg (B) or 50 mg (C) of protein per lane from the YS obtained at the indicated developmental stages and the indicated tissues (LH-L,
laying hen liver; EECs, endodermal epithelial cells) were separated by 10% SDS-PAGE under non-reducing conditions, blotted to nitrocellulose membranes and probed with our
rabbit antiserum directed against chicken MTP, followed by an HRP-coupled anti-rabbit secondary antibody as described in “Materials and methods section”. D and E, cryosections
of the YS tissue from 15-day-old chicken embryos were prepared as described in “Materials and methods section”. The sections were stained with our rabbit anti-ggMTP antiserum
(D) or with corresponding pre-immune serum (E). The position of the three germ layers are indicated by arrowheads. Images were acquired using a light microscope. Magniﬁcation,
40-fold.
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present in the YS after hatching. The levels of MTP protein in the YS
are in accordance with the results obtained by qPCR. The YS con-
sists of three germ layers, yolk sac ectoderm, mesoderm, and
endoderm [31]. Immunohistochemical staining of YS sections of 15-
day old embryos with anti-ggMTP antiserum revealed that MTP is
predominantly localized in the inner endodermal epithelial layer of
YS facing the yolk (Fig. 4D), as also shown by Western blot analysis
(Fig. 4C) and in our previous work [26]. No speciﬁc immunostaining
of sections was observed they were incubated with pre-immune
serum (Fig. 4E).
Finally, to test for de novo synthesis of apoB by the YS, pulse/
chase analysis with cultured YS fragments of 15-day (Fig. 5A) and
20-day (Fig. 5B) old embryos was performed. Newly synthesized
radiolabeled apoB100 was immunoprecipitated from the medium
and subjected to SDS-PAGE and autoradiographic analysis. A strong
signal corresponding to apoB-100 is detectable after a 6-hr chase
period in cultured YSs from both 15- (Fig. 5C) and 20-day old
(Fig. 5D) embryos.4. Discussion
Our ﬁndings support the notion that apoB100 is synthesized de
novo and secreted by the chicken yolk sac. Therefore, co-expression
of MTP indicates that it is also important for these processes in the
yolk sac. Previous studies have shown that apoB100 of plasma VLDL
in the laying hen undergoes partial proteolytic cleavage upon
receptor-mediated endocytosis into the oocyte, where it is stored as
yolk VLDL [32,33]. The characteristics of apoB in plasma VLDL
particles of adult animals and embryos are different from those of
VLDL particles found in yolk [27]. Yolk VLDL contains immunore-
active proteolytic fragments of apoB [32,33], whereas intact
apoB100 is present in the circulating plasma VLDL in embryos and
adult animals [27,32]. The YS has been suggested to be the major
source of lipoproteins and the site of cholesterol esteriﬁcation [34e
36]. Previous studies have shown the presence of apoB mRNA in YS
[37], and biochemical evidence has suggested that VLDL particles
are synthesized in YS [26,27].Fig. 5. ApoB secretion by the chicken yolk sac. YS tissue explants from 15-day old (A, C) and 2
1 h and chased for the indicated periods. Radiolabeled secreted apoB was immunoprecip
medium, and the results were quantiﬁed (C, D) as described in “Materials and methods seThe demonstration that MTP is produced during embryonic
development in the YS as well as in other organs known to secrete
lipoproteins supports the hypothesis that lipoproteins synthesized
in the embryo also contribute to the embryonic plasma pool of
apoB-containing lipoproteins. These tissues are the liver, small in-
testine, and, in contrast to mammals, the kidney. Thus, we analyzed
these four organs during different developmental stages for MTP
expression. There is ample evidence for the necessity of co-
expression of MTP and ApoB for the assembly of apoB into
triglyceride-rich lipoprotein particles [3e5]; for review see Ref. [38].
VLDL assembly and secretion by the liver have been extensively
analyzed in the chicken, since the biochemical and physiological
properties of the circulating particles are dramatically inﬂuenced by
estrogens [37,39e46]. Lazier et al. showed apoBmRNAexpression in
the embryonic liver from day 6.5 of development [37]. Tarugi at al.
observed a largehepatic cholesteryl ester store in the third trimester
of embryonic development, which intermittently increased at
hatching and decreased within a few days thereafter [47,48]. Noble
at al. suggested that the accumulation of cholesteryl esters in the
liver of late embryo derives from the uptake of cholesterol(ester)-
rich lipoproteins secreted from YS [36,49]. Our results comple-
ment these observations, as increased MTP and apoB production in
embryonic liver is compatible with the utilization of the accumu-
lated cholesterol for hepatic de-novo synthesis of lipoproteins.
The complex process of absorption of dietary lipids by the
enterocytes and their subsequent secretion as components of li-
poproteins into the circulatory system is also dependent on apoB
and MTP (for review see Ref. [19]). In mammals, the major lipo-
proteins secreted by the intestine are chylomicrons, which trans-
port dietary fat and fat-soluble vitamins into the blood for
distribution to target tissues. A key structural component of
mammalian chylomicrons is apoB48. Since chickens do not possess
the machinery required for the production of apoB48, so-called
portomicrons, the triglyceride-rich lipoproteins considered to be
equivalent to chylomicrons [14,50], harbor apoB100. Different from
the embryonic liver, we determined that the MTP transcript levels
in small intestine rose from negligible to substantial only shortly
before hatching, and that MTP protein is detectable in the intestine
only after hatching (Fig. 3). These ﬁndings extend the work by0-day old chicken embryos (B, D) were pulse-labeled with [35S]methionine/cysteine for
itated with our rabbit antiserum directed against chicken apoB from the conditioned
ction”.
C. Eresheim et al. / Biochimie 101 (2014) 67e74 73Lazier et al. who reported a lack of apoB mRNA in the embryonic
intestine before hatching [37]. This implies that in contrast to the
liver with its considerable pool of lipids accumulating during
embryogenesis, the embryonic intestinal cells lacking this large
pool are capable of lipoprotein synthesis and secretion only just
before and/or after hatching.
Besides the liver and small intestine, the kidney is a major
lipoprotein-producing organ in the chicken [46,51], which unlike
mammals, synthesize renal apoB at signiﬁcant levels [40,52]. Lazier
et al. [37] have shown apoBmRNA in the embryonic kidney starting
at day 7.5 of development. Our data demonstrate increasing levels
of MTP mRNA and protein in the kidney during embryogenesis,
with a further increase after hatching. Thus, the embryonic kidney,
like the liver, but in contrast to the intestine, appears to have the
capacity to serve as source of lipoproteins in the embryo. Immu-
nohistochemistry of embryonic liver, small intestine, and kidney
conﬁrmed the presence of MTP in the respective tissues, and also
provided insights into the localization of MTP in these tissues.
Taken together, our present ﬁndings strengthen the notion that
the synthesis and secretion of lipoproteins from embryonic tissues
is not limited to the yolk sac, but also is a physiologically important
feature of the developing liver, kidney, and, to a limited extent, the
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